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INTRODUCTION:  Malignant  paratesticular  tumours  are  rare.  We  report  a  case  of  paratesticular  malignant
mesothelioma  in a patient  who  had  excision  of  an adenomatoid  tumour  on  the same  site in 2 occasions
previously.
PRESENTATION  OF  CASE:  A middle  aged  man  who  had  an  adenomatoid  tumour  excised  from  his left
hemiscrotum  ﬁfteen  years  previously  was  referred  with  a suspicious  left  epididymal  lump.  This was
followed  up  sonographically  for 2  years  until  it showed  signs  of  enlargement  and  testicular  invasion;  it
was  then  managed  with  radical  orchidectomy.  The  histology  showed  paratesticular  epithelioid  malignant
mesothelioma.  The  patient  was  referred  to  the  Oncologists  for further  management.denomatoid  tumour DISCUSSION: Paratesticular  tumours  are  commonly  benign.  Scrotal  ultrasonography  is the  preferred  diag-
nostic  imaging  method.  Paratesticular  malignant  mesotheliomas  are  very  rare  and  appear  to  have  poor
prognosis.  The  optimal  adjuvant  treatment  post  radical  orchidectomy  is  not  established  yet.  In  our case
there  is suggestion  of  possible  malignant  transformation  from  previous  adenomatoid  tumour.
CONCLUSION: In  recurrent  paratesticular  tumours  the  clinicians  should  question  the possibility  of  malig-
nant  transformation  and  manage  these  cases  accordingly.
© 2013 Surgical Associates Ltd. Published by Elsevier Ltd. Open access under CC BY-NC-ND license. . Introduction
Malignant paratesticular tumours are rare clinical entities with
eterogenous pathogenesis and behaviour. We  report a case of
aratesticular malignant mesothelioma which developed on the
ite of previously excised epididymal adenomatoid tumour.
.  Presentation of case
A 55 year-old patient was referred to the Urology clinic due to a
alpable lump in the left hemiscrotum in 2009. He had previously
ad excision of a left epididymal adenomatoid tumour in 1993 and
urther exploration and excision of recurrent adenomatoid tumour
n the same site in 1997.
On  this presentation he complained of a small palpable lump
n the top of his left testis which was intermittently painful and
as grown in size over the previous 12 months. He had no other
igniﬁcant medical history. On clinical examination a small tender
ard lesion was felt on the left epididymal head. On subsequent
ltrasound scan a hyperechoic lobular area (1.6 cm in diameter)
as noted on the left epididymal head with a normal ipsilateral
esticle (Fig. 1). The differential diagnosis included a recurrent
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Open access under CC Badenomatoid tumour or rarer clinical entities such as sarcoma,
adenocarcinoma or mesothelioma.
The patient was offered exploration of the left hemiscrotum and
excision of the lesion but he refused as he was concerned of pos-
sible chronic scrotal pain. Thus a decision was made to keep the
lesion under surveillance with 6-monthly clinical and sonographic
evaluation.
The lesion did not change in morphology or size in the follow-
ing sequential scans for approximately 2 years, until there was
marginal increase in its size (2 cm in diameter) and ﬁnding of high
attenuation areas in the parenchyma of the left testicle (Fig. 2).
Due to the suggestion of inﬁltration to the testicle the patient was
offered and agreed to undergo left radical orchidectomy. The pre-
operative testicular tumour markers were normal.
Pathologically the lesion was  reported as a paratesticular epithe-
lioid malignant mesothelioma involving the epididymis, the tunica
vaginalis and superﬁcially inﬁltrating the adjacent testicle. Macro-
scopically the tumour gave a white and ﬁrm appearance to the
epididymis and microscopically it had a solid and focal tubu-
lopapillary pattern with numerous psammoma  bodies. There was
no sarcomatoid component or lymphovascular permeation. The
immunohistochemistry demonstrated positive staining for CK5/6,
WT1, BerEP4, CK7 and focally positive staining for Calretinin and
LeuMl (Fig. 3).
The  patient made an uneventful recovery and was referred to
the regional Oncology team for further management.
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or recurrent hydrocoele; in most cases the diagnosis is madeig. 1. Scrotal ultrasound scan demonstrating a hyperechoic area on the left epi-
idymalhead with a normal left testicular parenchyma.
. Discussion
Paratesticular tumours arise from the structures surrounding
he testicles including the epididymis, tunica albuginea, tunica
aginalis and the spermatic cord structures. The vast majority of
hem (70–78%)1,2 are benign with the commonest being the ade-
omatoid tumours.1 Clinical features of a painful or painless mass
o not help to distinguish a benign from a malignant lesion.2 Scrotal
ltrasonography remains the primary imaging method; generally
enign tumours appear as hyperechoic homogenous masses and
alignant tumours as either homogeneously hypoechoic or have a
eterogeneous pattern.3,4 Local surgical excision is the treatment
Fig. 3. Histopathologic examiFig. 2. Scrotal ultrasound scan demonstrating a marginal increase on the left epi-
didymalhead hyperechoic lesion and high attenuation areas in the left testicular
parenchyma.
for the benign paratesticular tumours.1 Local recurrences have
been reported but no malignant transformation has been reported
till now.
Malignant paratesticular tumours are rare; the commonest are
sarcomas.1 Paratesticular malignant mesotheliomas are even rarer
entities which usually present in patients between ages 55 and
75 years.5 Previous exposure to asbestos is considered as a risk
factor.5,6 Patients usually present with a palpable scrotal massintra-operatively due to lack of pathognomonic clinical and sono-
graphic characteristics.1,5 Radical orchidectomy is considered as
the ﬁrst line therapy. In cases of previous scrotal violation (i.e.
nation of the specimen.
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crotal exploration or epididymectomy for chronic scrotal pain)
xcision of ipsilateral hemiscrotum at the time of radical orchidec-
omy has been advocated.7 The optimal adjuvant treatment is
et to be conﬁrmed; Open retroperitoneal lymph node dissection
ith therapeutic intend has been reported in a case of metastatic
isease.8 Staging laparoscopic lymph node dissection has also been
erformed.7 Adjuvant radiotherapy or chemotherapy is generally
dvised.5 However strict recommendations on the role of adju-
ant therapy or staging laparoscopy cannot be made due to limited
vailable evidence.7 The tumour’s histological pattern and differ-
ntiation seems to play an important role in the prognosis.9 The
edian overall survival so far has been calculated to 24 months.10
In our case we report the diagnosis of a paratesticular mesothe-
ioma which was excised from the area of a previously excised
enign paratesticular tumour. This could potentially represent
alignant transformation. To our knowledge this has not been
ublished so far in the literature.
. Conclusion
In those cases of recurrent paratesticular tumours (previously
iagnosed as benign) the clinicians cannot continue to assume that
he pathology will be benign again. As the clinical behaviour of
he paratesticular tumours has not been completely understood we
dvocate a long term follow-up for the patients who  had a benign
aratesticular tumour excised.
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